2024
|
Invention
|
Acid phosphatase 3 ligands for targeted delivery applications. The present invention relates to l... |
|
Invention
|
Therapeutic combination of an anti-edb fibronectin domain antibody il2 or il12 fusion protein and... |
2023
|
Invention
|
Carbonic anhydrase ix ligands for targeted delivery applications. The present invention relates t... |
|
Invention
|
Multivalent fibroblast activation protein ligands for targeted delivery applications. The present... |
|
Invention
|
Conjugates of psma-binding moieties with cytotoxic agents.
A conjugate of Formula I or a pharmac... |
|
Invention
|
Conjugates of psma-binding moieties with cytotoxic agents. A conjugate of Formula I or a pharmace... |
|
Invention
|
High-affinity ligands of fibroblast activation protein for targeted delivery applications.
The p... |
|
Invention
|
High-affinity ligands of fibroblast activation protein for targeted delivery applications. The pr... |
2022
|
Invention
|
Radiolabelled fibroblast activation protein ligands. The present invention relates to ligands of ... |
|
Invention
|
Bivalent fibroblast activation protein ligands for targeted delivery applications.
The present i... |
|
Invention
|
Bivalent fibroblast activation protein ligands for targeted delivery applications. The present in... |
2021
|
Invention
|
Fibroblast activation protein ligands for targeted delivery applications.
The present invention ... |
|
Invention
|
Fibroblast activation protein ligands for targeted delivery applications. The present invention r... |
2019
|
Invention
|
Nucleic acid encoded chemical libraries. This invention relates to the production of nucleic acid... |
|
Invention
|
Production of encoded chemical libraries.
This invention relates to the synthesis of nucleic aci... |
2016
|
Invention
|
Targeted drug conjugates.
A targeted therapeutic agent comprising a compound of formula:
A tar... |
2015
|
Invention
|
Purification of dna-conjugate products. This invention relates to the purification of nucleic aci... |
|
Invention
|
Targeted drug conjugates. A targeted therapeutic agent comprising a compound of formula: B - L - ... |
2014
|
Invention
|
Production of encoded chemical libraries. This invention relates to the synthesis of nucleic acid... |
2010
|
Invention
|
Murine antibody display library. Murine antibody display libraries, "PHILOtop", for selection of ... |
2009
|
Invention
|
Cancer treatment.
The invention relates to the treatment of cancer, e.g. kidney cancer, using ch... |
|
Invention
|
Display library for antibody selection. Synthetic antibody display library containing human germl... |
|
Invention
|
Binding members for tenascin-c domain a2. Binding members, e.g. antibody molecules, for domain A2... |
2008
|
Invention
|
Dna-encoded chemical libraries. A method of preparing a DNA-encoded chemical library comprising m... |
2007
|
Invention
|
Albumin binding molecules and uses thereof. The invention relates to portable albumin binders, wh... |